Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Developments with PD1 and immunotherapy in melanoma

Prof Lex Eggermont – Institut Gustave Roussy, Villejuif, France

Developments with PD1 and immunotherapy in melanoma ( Prof Lex Eggermont – Institut Gustave Roussy, Villejuif, France )

Establishing immunotherapy as a standard in cancer treatment

Prof Drew Pardoll – Johns Hopkins University School of Medicine, Baltimore, USA

Establishing immunotherapy as a standard in cancer treatment ( Prof Drew Pardoll – Johns Hopkins University School of Medicine, Baltimore, USA )

ECC 2013 Preview: Scientific programme highlights

Prof Vincenzo Valentini and Ian Banks

ECC 2013 Preview: Scientific programme highlights ( Prof Vincenzo Valentini and Ian Banks )

Relapsed or progressive multiple myeloma

Dr Ruben Niesvizky - Weill Cornell Medical College, New York, USA

Relapsed or progressive multiple myeloma ( Dr Ruben Niesvizky - Weill Cornell Medical College, New York, USA )

Vemurafenib and ipilimumab for metastatic melanoma

Dr Caroline Robert - Institute Gustave Roussy, Paris, France

Vemurafenib and ipilimumab for metastatic melanoma ( Dr Caroline Robert - Institute Gustave Roussy, Paris, France )

Importance of the immune system in cancer

Prof Leif Håkansson - Linköping University Hospital, Sweden

Importance of the immune system in cancer ( Prof Leif Håkansson - Linköping University Hospital, Sweden )

Monoclonal antibodies and targeting them against cancer cells in lymphoma

Prof Ronald Levy - Stanford University, USA

Monoclonal antibodies and targeting them against cancer cells in lymphoma ( Prof Ronald Levy - Stanford University, USA )

Role of microenvironment and stroma in cancer therapy

Dr Stephen Ansell - Mayo Clinic, Rochester, USA

Role of microenvironment and stroma in cancer therapy ( Dr Stephen Ansell - Mayo Clinic, Rochester, USA )

ASCO 2013 highlights

Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA

ASCO 2013 highlights ( Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA )

Nivolumab with peptide vaccine in patients naive to or that failed ipilimumab

Dr Jeffrey Weber - Moffitt Cancer Center, Tampa, USA

Nivolumab with peptide vaccine in patients naive to or that failed ipilimumab ( Dr Jeffrey Weber - Moffitt Cancer Center, Tampa, USA )

Nivolumab blocking PD1 in lung cancer and melanoma

Dr Suzanne Topalian - Johns Hopkins Medical Center, Baltimore, USA

Nivolumab blocking PD1 in lung cancer and melanoma ( Dr Suzanne Topalian - Johns Hopkins Medical Center, Baltimore, USA )

Development and clinical trials of Z100

Dr Keiichi Fujiwara - Saitama Medical University, Saitama, Japan

Development and clinical trials of Z100 ( Dr Keiichi Fujiwara - Saitama Medical University, Saitama, Japan )

More from ecancer